Pulse Biosciences (PLSE) investor relations material

Executive summary

• The annual meeting will be held virtually on June 11, 2026, with voting on director elections and auditor ratification.

• Seven directors are nominated for election to serve until the 2027 annual meeting.

• Deloitte & Touche LLP is proposed for ratification as the independent auditor for fiscal year 2026.

• Stockholders of record as of April 28, 2026, are eligible to vote, with multiple voting methods available.

• The Board recommends voting in favor of all proposals.

Voting matters and shareholder proposals

• Proposal 1: Election of seven directors by plurality vote.

• Proposal 2: Ratification of Deloitte & Touche LLP as independent auditor for 2026, requiring majority approval.

• Shareholders may submit proposals for the 2027 meeting by January 11, 2027, following specific bylaw procedures.

• No cumulative voting is permitted; each share equals one vote.

Board of directors and corporate governance

• The Board separates the roles of CEO and Co-Chairmen for effective oversight.

• Five of seven directors are independent under Nasdaq rules.

• Committees include Audit, Compensation, Nominating and Corporate Governance, and Strategic Advisory.

• Directors are evaluated on ethics, experience, independence, and diversity.

• A code of business conduct and an amended insider trading policy are in place.